Correction: Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer.

Jun-Hui Sun,Tan-Yang Zhou,Yue-Lin Zhang,Guan-Hui Zhou,Chun-Hui Nie,Tong-Yin Zhu,Sheng-Qun Chen,Bao-Quan Wang,Song Ye,Yan Shen,Hua Guo,Wei-Lin Wang,Shu-Sen Zheng

DOI: https://doi.org/10.18632/oncotarget.24759

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14642.].

What problem does this paper attempt to address?

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Xia Li,Xiufeng Yin,Huafeng Wang,Jiansong Huang,Mengxia Yu,Zhixin Ma,Chenying Li,Yile Zhou,Xiao Yan,ShuJuan Huang,Jie Jin

DOI: https://doi.org/10.18632/oncotarget.27310

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14463.].
Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Jiaojiao Hao,Zhenglin Li,Changlin Zhang,Wendan Yu,Zhipeng Tang,Yixin Li,Xu Feng,Yue Gao,Quentin Liu,Wenlin Huang,Wei Guo,Wuguo Deng

DOI: https://doi.org/10.62347/suki5933

2024-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 13 in vol. 7, PMID: 28123844.].
Corrigendum: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib

Lei Zhang,Zhi-Ping Yan,Zhong-Heng Hou,Peng Huang,Min-Jie Yang,Shuai Zhang,Shen Zhang,Shao-Hua Zhang,Xiao-Li Zhu,Cai-Fang Ni,Qiang Li

DOI: https://doi.org/10.3389/fmolb.2021.727969

IF: 6.113

2021-08-30

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.624366.].

biochemistry & molecular biology
Correction To: Early Presence of Anti-Angiogenesis-related Adverse Events As a Potential Biomarker of Antitumor Efficacy in Metastatic Gastric Cancer Patients Treated with Apatinib: a Cohort Study

Xinyang Liu,Shukui Qin,Zhichao Wang,Jianming Xu,Jianping Xiong,Yuxian Bai,Zhehai Wang,Yan Yang,Guoping Sun,Liwei Wang,Leizhen Zheng,Nong Xu,Ying Cheng,Weijian Guo,Hao Yu,Tianshu Liu,Pagona Lagiou,Jin Li

DOI: https://doi.org/10.1186/s13045-017-0545-5

IF: 28.5

2017-01-01

Journal of Hematology & Oncology

Abstract:The original article [1] contains two errors in Table 2
Correction: DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin

Xilin Sun,Lili Yang,Xuefeng Yan,Yingying Sun,Dongliang Zhao,Yang Ji,Kai Wang,Xiaoyuan Chen,Baozhong Shen

DOI: https://doi.org/10.1371/journal.pone.0290861

IF: 3.7

2023-08-25

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0162601.].
Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer.

Jun-Hui Sun,Tan-Yang Zhou,Yue-Lin Zhang,Guan-Hui Zhou,Chun-Hui Nie,Tong-Yin Zhu,Sheng-Qun Chen,Bao-Quan Wang,Song Ye,Yan Shen,Hua Guo,Wei-Lin Wang,Shu-Sen Zheng

DOI: https://doi.org/10.18632/oncotarget.14642

2017-01-01

Oncotarget

Abstract:Purpose: The aim of the study was to evaluate the efficacy of transcatheter arterial chemoembolization (TACE) in treating patients with liver metastases from pancreatic cancer, and explore the prognostic risk factors. Results: Three of the 27 patients were totally recovered, and 12 were partially alleviated. The total efficacy rate was 55.6% (15/27). The median survival time was 13.6 months, and the 0.5-, 1-, 2-, 3-, and 5- year survival rates were 70.4% (19/27), 48.1% (13/27), 22.2% (6/27), 14.8 (4/27), 11.1% (3/27), respectively. None of the groups showed any severe complications. Univariate analysis showed that pathological type, concomitant therapies for liver metastasis, vascular supply, CA199 levels and extrahepatic metastasis were related to prognosis (P < 0.05). Multivariate analysis indicated that pancreatic cancer pathology and extrahepatic metastasis were independent risk factors influencing patients' prognosis (x(2) = 13.182, 17.989, P < 0.05). Methods: The clinical records of 27 patients with lliver metastases from pancreatic cancer diagnosed at the First Affiliated Hospital of Zhejiang University between May 2009 and May 2015 were retrospectively analyzed. The short-term and long-term efficacy and toxic side effects of TACE were observed. The prognostic risk factors were analyzed using Cox (proportional hazards) regression model. Conclusion: TACE is an effective therapy for treating liver metastases from pancreatic malignancy. Pathological type and extrahepatic metastasis of pancreatic tumor are independent risk factors for patients' prognosis. The prognosis of patients with liver metastasis from pancreatic neuroendocrine neoplasm is superior to that of extrahepatic metastasis.
Correction: Post-pancreaticoduodenectomy Hemorrhage: DSA Diagnosis and Endovascular Treatment.

Tan-Yang Zhou,Jun-Hui Sun,Yue-Lin Zhang,Guan-Hui Zhou,Chun-Hui Nie,Tong-Yin Zhu,Sheng-Qun Chen,Bao-Quan Wang,Wei-Lin Wang,Shu-Sen Zheng

DOI: https://doi.org/10.18632/oncotarget.24760

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.17450.].
Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.

Hongzhi Li,Weihua Yuan,Shufang Bin,Guang Wu,Panyuan Li,Min Liu,Jifeng Yang,Xiang Li,Kaiyan Yang,Haihua Gu

2022-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 688 in vol. 10, PMID: 32195036.].
Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Hang-Ping Yao,Liang Feng,Sreedhar Reddy Suthe,Ling-Hui Chen,Tian-Hao Weng,Chen-Yu Hu,Eun Sung Jun,Zhi-Gang Wu,Wei-Lin Wang,Song Cheol Kim,Xiang-Min Tong,Ming-Hai Wang

DOI: https://doi.org/10.1186/s40425-019-0571-7

IF: 12.469

2019-01-01

Journal for ImmunoTherapy of Cancer

Abstract:Following publication of the original article [1], the author reported two errors in the authors affiliations:
Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Haibo Xing,Mengting Tong,Jing Wang,Hanqing Hu,Chongya Zhai,Chunhui Huang,Da Li

DOI: https://doi.org/10.1155/2022/9767389

2022-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/3195025.].
Corrigendum: β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-Pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial–Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling

Zhang-qi Cao,Xue-xi Wang,Li Lu,Jing-wen Xu,Xiao-bin Li,Guang-ru Zhang,Zhan-jun Ma,An-chen Shi,Yan Wang,Yu-jun Song

DOI: https://doi.org/10.3389/fphar.2020.565535

IF: 5.6

2020-11-20

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2018.01525.].

pharmacology & pharmacy
Correction: Catalase-like Metal–organic Framework Nanoparticles to Enhance Radiotherapy in Hypoxic Cancer and Prevent Cancer Recurrence

Yuanyuan Chen,Hui Zhong,Jianbo Wang,Xiuyan Wan,Yanhua Li,Wei Pan,Na Li,Bo Tang

DOI: https://doi.org/10.1039/d0sc90108c

IF: 8.4

2020-01-01

Chemical Science

Abstract:Correction for ‘Catalase-like metal–organic framework nanoparticles to enhance radiotherapy in hypoxic cancer and prevent cancer recurrence’ by Yuanyuan Chen et al., Chem. Sci., 2019, 10, 5773–5778, DOI: 10.1039/C9SC00747D.
Corrigendum: Comparison of Clinical Outcomes Between Cone Beam CT-guided Thermal Ablation and Helical Tomotherapy in Pulmonary Metastases from Hepatocellular Carcinoma

Feihang Wang,Shisuo Fan,Qi Shi,Ding Zhao,Huaifeng Sun,Yav Sothea,Mengfei Wu,Huadan Song,Yi Chen,Jiemin Cheng,Zhao‐Chong Zeng,Yan Zhang,Jian He,Lingxiao Liu

DOI: https://doi.org/10.3389/fonc.2022.1038584

IF: 4.7

2022-01-01

Frontiers in Oncology

Abstract:In the published article, there was an error in affiliation of Zhaochong Zeng and Jian He. Instead of” Zhaochong Zeng2”and “Jian He2*”, the Shanghai Institute of Medical Imaging, Fudan University, Shanghai, China, it should be “Zhaochong Zeng4” and “Jian He4*”, the Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of Pancreatic Cancer: Erratum

Biao Zheng,Jianhua Qu,Kenoki Ohuchida,Haimin Feng,Stephen Jun Fei Chong,Zilong Yan,Yicui Piao,Peng Liu,Nan Sheng,Daiki Eguchi,Takao Ohtsuka,Kazuhiro Mizumoto,Zhong Liu,Shazib Pervaiz,Peng Gong,Masafumi Nakamura

DOI: https://doi.org/10.7150/thno.68023

IF: 11.6

2021-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.47001.].

medicine, research & experimental
Corrigendum: In vivo total or partial hepatectomy followed by ex vivo liver resection and autotransplantation for malignant tumors: a single center experience

Shaoyan Xu,Chenlu Hu,Zedong Jiang,Guogang Li,Bo Zhou,Zhenzhen Gao,Weilin Wang,Sheng Yan

DOI: https://doi.org/10.3389/fonc.2023.1251636

IF: 4.7

2023-08-11

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1214451.].

oncology
Correction: Up-Regulation of 91H Promotes Tumor Metastasis and Predicts Poor Prognosis for Patients with Colorectal Cancer.

Qiwen Deng,Bangshun He,Tianyi Gao,Yuqin Pan,Huiling Sun,Yeqiong Xu,Rui Li,Houqun Ying,Feng Wang,Xian Liu,Jie Chen,Shukui Wang

DOI: https://doi.org/10.1371/journal.pone.0304249

IF: 3.7

2024-01-01

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0103022.].
Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis

Qitong Chen,Dengjie Ouyang,Munawar Anwar,Ning Xie,Shouman Wang,Peizhi Fan,Liyuan Qian,Gannong Chen,Enxiang Zhou,Lei Guo,Xiaowen Gu,Boni Ding,Xiaohong Yang,Liping Liu,Chao Deng,Zhi Xiao,Jing Li,Yunqi Wang,Shan Zeng,Jinhui Hu,Wei Zhou,Bo Qiu,Zhongming Wang,Jie Weng,Mingwen Liu,Yi Li,Tiegang Tang,Jianguo Wang,Hui Zhang,Bin Dai,Wuping Tang,Tao Wu,Maoliang Xiao,Xiantao Li,Hailong Liu,Lai Li,Wenjun Yi,Quchang Ouyang

DOI: https://doi.org/10.3389/fonc.2021.661128

IF: 4.7

2021-03-05

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.00811.].

oncology
Correction: A Tissue Factor-Cascade-targeted Strategy to Tumor Vasculature: a Combination of EGFP-EGF1 Conjugation Nanoparticles with Photodynamic Therapy

Wei Shi,Yanxue Yin,Yao Wang,Bo Zhang,Pei Tan,Ting Jiang,Heng Mei,Jun Deng,Huafang Wang,Tao Guo,Zhiqing Pang,Yu Hu

DOI: https://doi.org/10.18632/oncotarget.25079

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.12922.].
Corrigendum to "Emulsifying Lipiodol with pH-Sensitive DOX@HmA nanoparticles for hepatocellular carcinoma TACE treatment eliminate metastasis" Mater. Today Bio, 23, 2023, 100873, ISSN 2590-0064

Qing Shi,Xingxing Zhang,Minmin Wu,Yuhan Xia,Yating Pan,Jialu Weng,Na Li,Xingjie Zan,Jinglin Xia

DOI: https://doi.org/10.1016/j.mtbio.2023.100916

2023-12-26

Abstract:[This corrects the article DOI: 10.1016/j.mtbio.2023.100873.].
Correction to: Therapeutic efficacy of the novel SHP2 degrader SHP2-D26, alone or in combination, against lung cancer is associated with modulation of p70S6K/S6, Bim and Mcl-1

Yunfu Deng,Guangzhi Ma,Karin A. Vallega,Dongsheng Wang,Mingliang Wang,Changwei Wang,Shaomeng Wang,Suresh S. Ramalingam,Shi-Yong Sun

DOI: https://doi.org/10.1038/s41417-022-00479-w

IF: 5.854

2022-05-10

Cancer Gene Therapy

Abstract:Cancer Gene Therapy, Published online: 10 May 2022; doi:10.1038/s41417-022-00479-w Correction to: Therapeutic efficacy of the novel SHP2 degrader SHP2-D26, alone or in combination, against lung cancer is associated with modulation of p70S6K/S6, Bim and Mcl-1

oncology,genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology

Correction: Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer.

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Corrigendum: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib

Correction To: Early Presence of Anti-Angiogenesis-related Adverse Events As a Potential Biomarker of Antitumor Efficacy in Metastatic Gastric Cancer Patients Treated with Apatinib: a Cohort Study

Correction: DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin

Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer.

Correction: Post-pancreaticoduodenectomy Hemorrhage: DSA Diagnosis and Endovascular Treatment.

Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Corrigendum: β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-Pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial–Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling

Correction: Catalase-like Metal–organic Framework Nanoparticles to Enhance Radiotherapy in Hypoxic Cancer and Prevent Cancer Recurrence

Corrigendum: Comparison of Clinical Outcomes Between Cone Beam CT-guided Thermal Ablation and Helical Tomotherapy in Pulmonary Metastases from Hepatocellular Carcinoma

LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of Pancreatic Cancer: Erratum

Corrigendum: In vivo total or partial hepatectomy followed by ex vivo liver resection and autotransplantation for malignant tumors: a single center experience

Correction: Up-Regulation of 91H Promotes Tumor Metastasis and Predicts Poor Prognosis for Patients with Colorectal Cancer.

Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis

Correction: A Tissue Factor-Cascade-targeted Strategy to Tumor Vasculature: a Combination of EGFP-EGF1 Conjugation Nanoparticles with Photodynamic Therapy

Corrigendum to "Emulsifying Lipiodol with pH-Sensitive DOX@HmA nanoparticles for hepatocellular carcinoma TACE treatment eliminate metastasis" Mater. Today Bio, 23, 2023, 100873, ISSN 2590-0064

Correction to: Therapeutic efficacy of the novel SHP2 degrader SHP2-D26, alone or in combination, against lung cancer is associated with modulation of p70S6K/S6, Bim and Mcl-1